Episode: 173 - A Continued Conversation: Fred Khosravi on Transforming a Medical Invention to an Exceptional Innovation
Listen now
Description
Fred Khosravi, chairman and CEO of Imperative Care, returns to the podcast for another engaging conversation with host Geoff Pardo about his personal and professional experiences in the medtech space. He speaks about the elements of preparedness that help entrepreneurs seize new opportunities, the importance of maintaining intellectual honesty in one’s work, and why a “market-first” mentality leads to industry success. He says, “It’s not a great medical innovation unless it ends up helping a lot of patients. Otherwise, it’s just a great invention.”  Khosravi generously shares three decades worth of entrepreneurial wisdom and recounts stories of the people who profoundly impacted his career. He talks about viewing investors as partners not parents, the attributes that spur venture capitalists to invest in a CEO, the lessons learned from developing the number one intravascular filter in the global market, and his work at Imperative Care—a stand-alone comprehensive stroke and thrombectomy company. He also explains why he believes “freedom and innovation” set the American medtech industry apart and the path forward to make it even better.   Links from this episode:   Gilde Healthcare Imperative Care  Incept Medical Incubator (Axtria, Ostial, Neurolutions, Instylla, Tulavi Therapeutics) 
More Episodes
In this episode of Medtech Talk, host Geoff Pardo and Conor Hanley, PhD, CEO of FIRE1, discuss various topics ranging from leadership to entrepreneurship to raising funds. Hanely also talks about lessons learned about raising capital at BiancaMed, how he keeps investors on the same page, how he...
Published 04/30/24
Published 04/30/24
In this month’s episode of Medtech Talk, host Geoff Pardo speaks with Rodney Perkins, M.D., serial medtech inventor and founder of several companies, including Collagen Corporation and Laserscope. Perkins delves into his extensive history as one of the industry’s most prolific and successful...
Published 03/27/24